NDC 70436-203 – Dobutamine
Dobutamine Hydrochloride 250 mg/20mL · Injection · Intravenous
Product NDC70436-203
Product details
- Brand name
- Dobutamine
- Generic name
- Dobutamine
- Labeler
- Slate Run Pharmaceuticals
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- ANDA · ANDA216131
- Marketed since
- April 3, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- beta-Adrenergic Agonist
Active ingredients
- Dobutamine Hydrochloride 250 mg/20mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 70436-203-80 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70436-203-80) / 20 mL in 1 VIAL, SINGLE-DOSE | Apr 3, 2023 |
| 70436-203-82 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70436-203-82) / 20 mL in 1 VIAL, SINGLE-DOSE | Apr 3, 2023 |
Other Dobutamine products
- 51662-1337 Dobutamine Hydrochloride 12.5 mg/mL · Injection, Solution, Concentrate · HF Acquisition Co LLC, DBA HealthFirst
- 0143-9141 Dobutamine Hydrochloride 12.5 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0409-2344 Dobutamine Hydrochloride 12.5 mg/mL · Injection, Solution, Concentrate · Hospira, Inc.